The International Society for Biological Therapy of Cancer (iSBTc): Oncology Biologics Development PrimerFebruary 28-29, 2008Marriott Gaithersburg Washington Center in Gaithersburg, MDProgram OrganizersSusan Jerian, MD - OncoRD, Inc.Carl H. June, MD - University of PennsylvaniaMercedes Serabian, MS, DABT - Food and Drug Administration, CBERRobert J. Zimmerman, SD - Zimmerman ConsultingProgram SummaryiSBTc created the Oncology Biologics Development Primer (OBDP) to meet the needs of the biological therapy community by educating physicians and researchers on the worldwide regulatory paths for biological therapy development. Though facilitating collaborative interactions between regulators, preclinical scientists, clinical investigators and industry, the OBDP will help ensure that active, innovative new therapies are rapidly and appropriately moved into clinical testing. Target AudiencePhysicians and scientists in academia, industry and regulatory agencies who have an interest in the strategic, preclinical, clinical and regulatory aspects of efficient oncology biologics development.
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us